Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4619 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]1([H])C[C@@]2([H])[C@]3([H])C[C@@]([H])(C4=CC(=O)C=C[C@]4(C)[C@@]3([H])[C@]([H])(C[C@]2(C)[C@]1(C(=O)CO)O)O)F
InChI
InChIKey=MKPDWECBUAZOHP-AFYJWTTESA-N
InChI=1S/C22H29FO5/c1-11-6-14-13-8-16(23)15-7-12(25)4-5-20(15,2)19(13)17(26)9-21(14,3)22(11,28)18(27)10-24/h4-5,7,11,13-14,16-17,19,24,26,28H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19-,20+,21+,22+/m1/s1
Molecular Formula | C22H29FO5 |
Molecular Weight | 392.4619 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Paramethasone is a glucocorticoid. It exerts anti-inflammatory and immunosuppressant actions. Paramethasone stimulates the synthesis of enzymes needed to decrease anti-inflammatory response. It suppresses the immune system by reducing activity and volume of the lymphatic system, thus producing lymphocytopenia decreasing passage of immune complexes and possibly by depressing reactivity of tissue to antigen-antibody interactions.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Pseudo-allergic reactions to corticosteroids: diagnosis and alternatives. | 1995 May-Jun |
|
Two cases of specific adverse reactions to systemic corticosteroids. | 1996 Sep-Oct |
|
[Chronic adhesive arachnoiditis following epidural paramethasone]. | 1997 Dec |
|
Surgical decompression versus local steroid injection in carpal tunnel syndrome: a one-year, prospective, randomized, open, controlled clinical trial. | 2005 Feb |
|
Tachon's syndrome (suracute back and/or thoracic pain following local injections of corticosteroids). A report of 318 French cases. | 2005 Jan |
|
[Hiccups crisis following paramethasone intraarticular injection]. | 2005 Jun 25 |
|
Epidural dextran-40 and paramethasone injection for treatment of spontaneous intracranial hypotension. | 2006 Jun |
|
Adalimumab for the treatment of fistulas in patients with Crohn's disease. | 2009 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 08:08:15 UTC 2021
by
admin
on
Sat Jun 26 08:08:15 UTC 2021
|
Record UNII |
VFC6ZX3584
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QH02AB05
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
||
|
NCI_THESAURUS |
C521
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
||
|
WHO-ATC |
H02AB05
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C66309
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
M8403
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | Merck Index | ||
|
DB01384
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
VFC6ZX3584
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
SUB09614MIG
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
D010248
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
PARAMETHASONE
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
5875
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
CHEMBL1200342
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
53-33-8
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
7910
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | RxNorm | ||
|
200-169-2
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
3376
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
1096
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY | |||
|
53-33-8
Created by
admin on Sat Jun 26 08:08:15 UTC 2021 , Edited by admin on Sat Jun 26 08:08:15 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |